galactosamine has been researched along with thromboplastin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Anan, K; Ijiri, H; Sano, T; Shimamoto, T; Yamazaki, H | 1 |
Ai, Q; Ao, JE; Duan, R; Ge, P; Gong, X; Lin, L; Zhang, L | 1 |
2 other study(ies) available for galactosamine and thromboplastin
Article | Year |
---|---|
Isolation and chemical analyses of platelet-clumping substance in blood.
Topics: Animals; Blood Coagulation; Blood Proteins; Chromatography, Gel; Electrophoresis, Disc; Galactosamine; Glucosamine; Goats; Hemostasis; Heparin; Hexoses; Immunoelectrophoresis; Male; Mucoproteins; Oxalates; Plasma; Platelet Adhesiveness; Prothrombin Time; Thromboplastin; Ultracentrifugation; Uronic Acids | 1974 |
Metformin suppresses intrahepatic coagulation activation in mice with lipopolysaccharide/D‑galactosamine‑induced fulminant hepatitis.
Topics: Animals; Anti-Inflammatory Agents; Blood Coagulation; Disease Models, Animal; Erythropoietin; Galactosamine; Hepatitis; Hypoglycemic Agents; Hypoxia-Inducible Factor 1, alpha Subunit; Inflammation; Interleukin-6; Lactic Acid; Lipopolysaccharides; Liver; Matrix Metalloproteinase 3; Metformin; Mice; NF-kappa B; Plasminogen Activator Inhibitor 1; RNA, Messenger; Thromboplastin; Up-Regulation; Vascular Endothelial Growth Factor A | 2015 |